Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Nurix Therapeutics Inc (NQ: NRIX )

21.26 -0.79 (-3.58%)
Streaming Delayed Price Updated: 12:20 PM EST, Nov 25, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Nurix Therapeutics Inc

< Previous 1 2 3 4 Next >
BlackBerry, Nurix Therapeutics, Tesla And Other Big Stocks Moving Higher On Tuesday
U.S. stocks were lower, with the Dow Jones index falling over 200 points on Tuesday. Shares of BlackBerry Limited (NYSE: BB) rose sharply during Tuesday’s session. 
Via Benzinga
Topics Stocks
Exposures US Equities
Critical Insights From Nurix Therapeutics Analyst Ratings: What You Need To Know
Via Benzinga
Analyst Scoreboard: 7 Ratings For Nurix Therapeutics
Via Benzinga
Decoding 4 Analyst Evaluations For Nurix Therapeutics
Via Benzinga
Bit Digital, Cipher Mining And Other Big Stocks Moving Higher In Thursday's Pre-Market Session
U.S. stock futures were mixed this morning, with the Dow Jones futures falling around 40 points on Thursday. Here are some big stocks recording gains in today’s pre-market trading session. 
Via Benzinga
Topics Stocks
Exposures US Equities
The Latest Analyst Ratings for Nurix Therapeutics
Via Benzinga
What 4 Analyst Ratings Have To Say About Nurix Therapeutics
Via Benzinga
Analyst Ratings for Nurix Therapeutics
Via Benzinga
Judith A. Reinsdorf and Katherine M. Sandstrom Named to Toll Brothers Board of Directors
From Toll Brothers, Inc.
Via GlobeNewswire
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Cathie Wood-Led Ark Invest Sells Over $6.5M Worth Of Tesla Stock, What's Going On?
Via Benzinga
Why Is Cancer Focused Nurix Therapeutics Stock Trading Higher Today?
Nurix Therapeutics Inc (NASDAQ: NRIX) has entered into a multi-year, multi-target strategic collaboration agreement with Seagen Inc (NASDAQ: SGEN) to advance a new class of medicines called... 
Via Benzinga
Nurix Therapeutics's Return On Capital Employed Insights
Via Benzinga
Analyst Ratings for Nurix Therapeutics
Via Benzinga
Nurix Therapeutics Inc. (NASDAQ: NRIX) Highlighted for Surprising Price Action
Via Investor Brand Network
Designer Brands, Calavo Growers, Couchbase And Other Big Stocks Moving Higher On Thursday
U.S. stocks traded mostly lower, with the Nasdaq Composite falling around 200 points on Thursday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Topics Stocks
Exposures US Equities
Analyst Cuts Nurix Therapeutics Price Target By 38%, Cites Lymphoma Data
HC Wainwright analyst Robert Burns has lowered the price target for Nurix Therapeutics Inc (NASDAQ: NRIX)  
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
It's time to start the final trading day of the week with a breakdown of the biggest pre-market stock movers for Friday! 
Via InvestorPlace
JPMorgan, Citigroup, QuidelOrtho And Other Big Stocks Moving Higher On Friday
U.S. stocks traded lower, with the Dow Jones dropping over 150 points on Friday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Expert Ratings for Nurix Therapeutics
Via Benzinga
Gilead Exercises First License Option Under Agreement With Nurix Therapeutics
Via Benzinga
Analyst Ratings for Nurix Therapeutics
Via Benzinga
Gilead Exercises Option to License Nurix’s IRAK4 Targeted Protein Degrader Development Candidate, NX-0479
From Gilead Sciences, Inc.
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For March 9, 2023
Via Benzinga
Nurix Therapeutics's Return On Capital Employed Overview
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 28, 2023
Via Benzinga
The Top 5 Stocks Cathie Wood Bought and Sold This Week
Cathie Wood's flagship ETF, the ARK Innovation ETF, hit a five-year and 52-week low this week, casting doubts on the investment manager. 
Via InvestorPlace
CSX, Veris Residential And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
U.S. stock futures traded lower this morning. Here are some big stocks recording gains in today’s pre-market trading session. 
Via Benzinga
Cathie Wood Loads Up Over $6.7M In Adobe Stock As It Tumbles 27% In A Month — Also Adds Stake In This Biopharma Company
Cathie Wood-led ARK Investment Management bought over 23,000 shares of software maker Adobe Inc (NASDAQ: ADBE) through the 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 11, 2022
Upgrades 
Via Benzinga
< Previous 1 2 3 4 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.